318 results on '"Xie, Hong-Guang"'
Search Results
2. Enhanced metabolic activation of and platelet response to clopidogrel in T cell-deficient mice through induction of Cyp2c and Cyp3a and inhibition of Ces1
3. Choline and trimethylamine N-oxide impair metabolic activation of and platelet response to clopidogrel through activation of the NOX/ROS/Nrf2/CES1 pathway
4. Biologics and Biosimilars 101
5. Biologics and Biosimilars
6. Development and validation of a UPLC–MS/MS method for simultaneous determination of vicagrel and its major metabolites in rat or human plasma: An optimized novel strategy for the stabilization of vicagrel
7. Vicagrel enhances aspirin-induced inhibition of both platelet aggregation and thrombus formation in rodents due to its decreased metabolic inactivation
8. Aspirin Attenuates the Bioactivation of and Platelet Response to Vicagrel in Mice
9. Development of Hybrid Rice Variety FY7206 with Blast Resistance Gene Pid3 and Cold Tolerance Gene Ctb1
10. Vicagrel is hydrolyzed by Raf kinase inhibitor protein in human intestine
11. Pharmacogenomics and Personalized Medicine of the Antiplatelet Drugs
12. Human UGT2B7 is the major isoform responsible for the glucuronidation of clopidogrel carboxylate
13. Overcoming Clopidogrel Resistance: Three Promising Novel Antiplatelet Drugs Developed in China
14. Attenuated expression of the tight junction proteins is involved in clopidogrel-induced gastric injury through p38 MAPK activation
15. Is platelet responsiveness to clopidogrel attenuated in overweight or obese patients and why? A reverse translational study in mice
16. Effects of folic acid supplementation on the pharmacokinetics and anticoagulant effect of warfarin: An open-label, prospective study of long-term administration in adults
17. Short-term standard alcohol consumption enhances platelet response to clopidogrel through inhibition of Nrf2/Ces1 pathway and induction of Cyp2c in mice
18. The molecular mechanism underlying the induction of hepatic MRP3 expression and function by omeprazole†
19. Influence of CYP2C19 loss-of-function variants on the antiplatelet effects and cardiovascular events in clopidogrel-treated Chinese patients undergoing percutaneous coronary intervention
20. Berberine improves pressure overload-induced cardiac hypertrophy and dysfunction through enhanced autophagy
21. P-glycoprotein deficiency enhances metabolic activation of and platelet response to clopidogrel through marked up-regulation of Cyp3a11 in mice: Direct evidence for the interplay between P-glycoprotein and Cyp3a
22. Antiepileptics Topiramate and Levetiracetam Alleviate Behavioral Deficits and Reduce Neuropathology in APPswe/PS1dE9 Transgenic Mice
23. Efffect of the ABCC3 –211C/T polymorphism on clopidogrel responsiveness in patients with percutaneous coronary intervention
24. Qualified kidney biomarkers and their potential significance in drug safety evaluation and prediction
25. Is platelet responsiveness to clopidogrel attenuated in overweight or obese patients and why? A reverse translational study in mice.
26. The effect of common polymorphisms of the beta(sub 2)-adrenergic receptor on agonist-mediated vascular desensitization
27. Clonidine Clearance Matures Rapidly During the Early Postnatal Period: A Population Pharmacokinetic Analysis in Newborns With Neonatal Abstinence Syndrome
28. Individual variability in the disposition of and response to clopidogrel: Pharmacogenomics and beyond
29. Multidrug Resistance–Associated Protein 3 Is Responsible for the Efflux Transport of Curcumin Glucuronide from Hepatocytes to the Blood
30. Magnetic properties of layered chiral topological magnetic material Cr1/3NbS2
31. Personalized immunosuppressive therapy in pediatric heart transplantation: Progress, pitfalls and promises☆
32. INDUCTION OF CYP3A IN PRIMARY CULTURES OF HUMAN HEPATOCYTES BY GINKGOLIDES A AND B
33. EFFECTS OF INDIVIDUAL GINSENOSIDES, GINKGOLIDES AND FLAVONOIDS ON CYP2C19 AND CYP2D6 ACTIVITY IN HUMAN LIVER MICROSOMES
34. Gene variants in noncoding regions and their possible consequences
35. Variations in the α2A-adrenergic receptor gene and their functional effects
36. Pharmacogenomics steps toward personalized medicine
37. Additional discussions regarding the altered metabolism and transport of omeprazole after long-term use of St Johnʼs wort
38. St Johnʼs wort-associated drug interactions: Short-term inhibition and long-term induction?
39. Pharmacogenetics and Rheumatology: Molecular Mechanisms Contributing to Variability in Drug Response
40. No association of the Asp298 variant of the endothelial nitric oxide synthase gene with preeclampsia
41. α1A-Adrenergic receptor polymorphism and vascular response
42. Genetic variability in CYP3A5 and its possible consequences
43. β2-Adrenergic receptor genotype and preterm delivery
44. Beta(sub 2)-adrenergic receptor genotype and preterm delivery
45. Original Articles: The Effect of Common Polymorphisms of the (beta)(2))-Adrenergic Receptor on Agonist-Mediated Vascular Desensitization
46. Identification of functionally variant MDR1 alleles among European Americans and African Americans
47. Human β2-adrenergic receptor polymorphisms: No association with essential hypertension in black or white Americans
48. Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese population
49. Effect of the gene dosage of CYP2C19 on diazepam metabolism in Chinese subjects
50. Enhanced responsiveness of platelets to vicagrel in IL‐10‐deficient mice through STAT3‐dependent up‐regulation of the hydrolase arylacetamide deacetylase in the intestine
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.